Martin Avenue Pharmacy Inc. has issued a recall of several prescription medications sold to health care providers and consumers by prescription in seven states, including Wisconsin.
The medication was supposed to be sterile, but Martin Avenue failed to conduct proper quality controls, which means the medications may not actually be sterile. That could leave patients at risk for infection, according to the Food and Drug Administration.
Among the drugs recalled are atropine, fentanyl, morphine and lidocaine.
The affected prescription medications were sold through Aug. 20 this year in Wisconsin, Illinois, Ohio, Michigan, Florida, Alabama and Texas. The sterile preparations recall was posted Tuesday on the FDA's website after an FDA inspection revealed problems.
Among the recalled medications are injectable drugs, powders and solutions:
- Atropine sulfate
- Bacteriostatic water for injection
- Benzalkonium chloride
- Bupivacaine HCL
- Calcium chloride
- Cefazolin forte
- Chlorhexidine gloconate
- Chorionic gonadotropin
- Cromolym sodium
- Dexamethasone sodium phosphate
- Hydrochloric acid
- Morphine sulfate
- Paraben water for injection
- Phentolamine mesylate
- Polyhexamethylene biguanide
- Prednisolone acetate
- Quad mix, injectable
- Rescue solution
- Sodium tetradecyl
- Tacrolimus oil
- Testosterone cypionate, injectable
- Tetracycline powder kits
- Tri-mix, injectable
For a full list of products affected by the recall, see the FDA's website. It has details on lot numbers and "discard after" dates.
Patients and medical offices are advised to stop using the products and report any adverse events or side effects related to the use of the products to FDA. (Details below.)
Martin Avenue Pharmacy said it's notifying its customers of the recall by fax, mail, phone or email with instructions on how to return the recalled products.
Consumers or health care providers can contact Martin Avenue Pharmacy with questions by calling (630) 355-6400 or toll free (888) 355-6492 Monday through Friday between 9 a.m. and 7 p.m. Central time. Customers can also email firstname.lastname@example.org.
Adverse effects or side effects can be reported to the FDA 's MedWatch Safety Information and Adverse Event Reporting Program online or by downloading the report form and mailing it to the address on the form or faxing it to (800) FDA-0178. That's (800) 332-0178.